Episode Details

Back to Episodes

Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics

Season 2026 Episode 822 Published 1 week ago
Description

This interview is disseminated on behalf of Conexeu Sciences Inc.

Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration.

Learn more: https://www.conexeu.com/

Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hU

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us